Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-07-02Clinical Trial Update: Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma [EARLY_Phase 1]
An early-phase study evaluating simvastatin to overcome chemotherapy resistance in relapsed or refractory multiple myeloma has been withdraw…
-
FDA approval · 2018-06-29FDA Approved: ZOLEDRONIC ACID — Original Application (Gland Pharma Limited)
The FDA approved an Original Application for a generic zoledronic acid product by Gland Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma [Phase 2]
Phase 2 trial update of a Bruton's tyrosine kinase inhibitor in relapsed/refractory multiple myeloma has completed with results posted.
-
CLINICAL_TRIALS research · 2018-06-19Clinical Trial Update: The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd) [Phase 3]
Phase 3 clinical trial investigating ixazomib in autologous stem cell transplant for relapsed multiple myeloma. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2018-06-18Clinical Trial Update: Study of BCMA CAR-T in Multiple Myeloma [EARLY_Phase 1]
An early-phase study of BCMA-targeted CAR-T cell therapy for relapsed and refractory multiple myeloma; status is currently unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma [NA]
A completed clinical trial evaluating touchscreen-based geriatric assessment and frailty screening in adults with multiple myeloma, sponsore…
-
CLINICAL_TRIALS research · 2018-06-14Clinical Trial Update: WB-EMS and Nutrition in Patients With Hematological Malignancies [NA]
A trial update describing the evaluation of whole-body electromyostimulation (WB-EMS) with nutrition in patients with hematologic malignanci…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) [Phase 3]
Phase 3 trial evaluating stem cell transplant with lenalidomide maintenance for multiple myeloma has completed; results posted in 2018.
-
CLINICAL_TRIALS research · 2018-06-11Clinical Trial Update: Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients [Phase 3]
A Phase 3 clinical trial update evaluating a multi-agent combination including thalidomide, lenalidomide, carfilzomib, bortezomib, and vorin…
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Efficacy Study of CYT997 in Multiple Myeloma [Phase 2]
A Phase 2 efficacy trial of CYT997 in relapsed and refractory multiple myeloma has been terminated.
-
FDA approval · 2018-06-07FDA Approved: KYPROLIS — Supplemental Application (Onyx Pharmaceuticals, Inc.)
FDA approved a supplemental application for KYPROLIS (carfilzomib) submitted by Onyx Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A phase 2 trial evaluating the combination of bendamustine hydrochloride, bortezomib, and dexamethasone in newly diagnosed multiple myeloma …
-
CLINICAL_TRIALS research · 2018-06-07Clinical Trial Update: Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma [Phase 2]
Phase 2 clinical trial evaluating the combination of daratumumab, thalidomide, and dexamethasone in relapsed and/or refractory multiple myel…
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone
Update on a completed non-interventional study evaluating palliative therapy in multiple myeloma using a combination of lenalidomide and dex…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma [Phase 1]
Phase 1 clinical trial update on AR-42 in adults with advanced or relapsed multiple myeloma, chronic lymphocytic leukemia, and various lymph…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant [Phase 2]
Phase 2 trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for multiple myeloma after allogeneic transplant was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands [Phase 1]
Phase 1 safety study of CYAD-01, CAR T cells targeting NKG2D-ligands, completed; evaluated in acute myeloid leukemia, myelodysplastic syndro…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma [Phase 2]
Phase 2 trial investigating MEDI-551 as maintenance therapy after allogeneic stem cell transplantation in multiple myeloma; study terminated…
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1]
A Phase 1 study evaluating a regimen of bortezomib, melphalan, and total-body irradiation before stem cell transplantation in patients with …
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma [Phase 1]
Phase 1 trial evaluating Nivolumab for patients with refractory or relapsed multiple myeloma; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease
This clinical trial update reports results from a retrospective chart review of second-line lenalidomide/dexamethasone therapy and treatment…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating panobinostat with everolimus in recurrent hematologic malignancies including multiple myeloma and non-Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib [Phase 2]
Phase 2 study assessing efficacy and safety of pomalidomide plus dexamethasone in patients with multiple myeloma who relapsed after lenalido…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols [Phase 2]
A Phase 2 study evaluated extending carfilzomib therapy in patients previously enrolled in carfilzomib treatment protocols. The trial has co…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma [Phase 1]
Phase 1 trial evaluating Rituximab, Yttrium Y-90 ibritumomab tiuxetan, and Melphalan with autologous stem cell transplant in patients with p…